SCHEMBL2158276

SCHEMBL2158276

NC(=O)C1(c2ccccc2)CN(C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.46
AKR1C1 Q04828 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
OPRL1 P41146 2/20 0.43
OPRM1 P35372 2/20 0.42
CYP2C9 P11712 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
HDAC4 P56524 3/20 0.41
TET3 O43151 1/20 0.41
FBXL19 Q6PCT2 1/20 0.41
CXXC5 Q7LFL8 1/20 0.41
TET1 Q8NFU7 1/20 0.41
KDM2B Q8NHM5 1/20 0.41
CXXC4 Q9H2H0 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2158208 0.85 AKR1C1 (0.57) HSD11B1AKR1C1KMT2AMEN1HDAC4
SCHEMBL12397137 0.81 LMNA (0.50) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL2722547 0.78 AKR1C1 (0.57) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL501923 0.78 AKR1C1 (0.57) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL2158338 0.77 HSD11B1 (0.49) HSD11B1AKR1C1KMT2AMEN1OPRM1
SCHEMBL19331351 0.77 OPRM1 (0.42) HSD11B1AKR1C1KMT2AMEN1OPRM1
Hydrochloric Acid SCHEMBL1804765 0.76 AKR1C1 (0.55) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL2159431 0.76 AKR1C1 (0.40) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL8365912 0.75 HSD11B1 (0.58) HSD11B1AKR1C1KMT2AMEN1OPRL1
SCHEMBL42114 0.75 AKR1C1 (0.70) HSD11B1AKR1C1KMT2AMEN1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410137-B2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2013-04-02 US disclosed
US-20110183960-A1 THIOPHENE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183960-A1 THIOPHENE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF NR3C2, NR1H3, NR1H2 HSD11B1 274/4885AKR1C1 414/4885KMT2A 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.